Pamela Crutchfield BSW

Recommended Articles

• The Best Ways to Prevent Jock Itch

  Jock Itch, a fungal attack that infects, inflames and irritates the skin resulting in excessive itching and sometimes painful sores, can be prevented with the right mix of personal hygiene and a clean, dry groin. Here are the most useful tips for preventing and combating the infection. Observe...

• The Benefits of a Massage for People With Fibromyalgia

  Fibromyalgia causes pain throughout the body. It also causes tenderness in joints, muscles, tendons and other soft tissues. Although there is no cure for fibromyalgia, pain can be managed.Massage is considered effective and beneficial in managing pain caused by fibromyalgia.About 5 million Americans...

• The Risks of Oxycodone for Fibromyalgia Patients

  Fibromyalgia is difficult to identify, diagnose, and treat. Its symptoms are strikingly similar to other diseases that cause excessive fatigue, stress, and depression. People without the disease normally do not understand it. However, awareness around the disease is slowly improving.In the past,...

• In Plain Sight: Vision Changes Linked to Parkinson’s Disease

  Parkinson’s disease is a chronic, progressive movement disorder that affects the nervous system. It is characterized by gradual death and breakdown of nerve cells in the brain resulting in the decreased production of a chemical messenger called dopamine. Reduced dopamine levels cause abnormal...

• What to Avoid If You Have Lyme Disease

  If you get Lyme disease, it may be necessary to make a change in your lifestyle, particularly your diet, in order to make the treatment time shorter. As you probably already know, lyme disease cannot be cured. What can be done is to treat the symptoms of the disease. To quicken the recovery process,...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...